SCHEMBL5585922

SCHEMBL5585922

COc1ccc(C(=O)/C=C/C(=O)Nc2ccccc2)cc1OC

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 4/20 0.66
KMT2A Q03164 4/20 0.66
NPC1 O15118 3/20 0.66
RAB9A P51151 2/20 0.66
STAT1 P42224 1/20 0.66
SMN1; SMN2 Q16637 1/20 0.66
TNFRSF1A P19438 1/20 0.63
MAPT P10636 7/20 0.58
CYP3A4 P08684 1/20 0.58
ALDH1A1 P00352 3/20 0.56
LMNA P02545 3/20 0.56
USP2 O75604 1/20 0.56
MAPK1 P28482 1/20 0.56
ABCG2 Q9UNQ0 3/20 0.56
ABCB1 P08183 2/20 0.56
GAA P10253 1/20 0.56
HPGD P15428 1/20 0.56
ALOX12 P18054 1/20 0.56
KDM4E B2RXH2 2/20 0.55
ATM Q13315 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5585927 1.00 MEN1 (0.66) MEN1KMT2ANPC1RAB9ASTAT1
SCHEMBL5585779 0.88 ALDH1A1 (0.63) MEN1KMT2ANPC1RAB9ASTAT1
SCHEMBL5585775 0.88 ALDH1A1 (0.63) MEN1KMT2ANPC1RAB9ASTAT1
SCHEMBL5585582 0.84 TNFRSF1A (0.75) MEN1KMT2ANPC1RAB9ATNFRSF1A
SCHEMBL5585584 0.84 TNFRSF1A (0.75) MEN1KMT2ANPC1RAB9ATNFRSF1A
SCHEMBL11650530 0.83 TNFRSF1A (0.55) MEN1KMT2ANPC1RAB9ASMN1; SMN2
SCHEMBL11653132 0.82 NPSR1 (0.57) MEN1KMT2ANPC1RAB9ASMN1; SMN2
SCHEMBL4141962 0.80 MEN1 (0.89) MEN1KMT2ANPC1RAB9AMAPT
SCHEMBL2839312 0.80 MEN1 (1.00) MEN1KMT2ANPC1RAB9ASTAT1
SCHEMBL2849002 0.80 MEN1 (1.00) MEN1KMT2ANPC1RAB9ASTAT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7161022-B2 Process for producing 4-phenyl-4-oxo-2-butenoic ester derivative FUJIFILM FINECHEMICALS CO., LTD. (JP) 2007-01-09 US disclosed
US-20050176994-A1 Process for producing 4-phenyl-4-oxo-2-butenoic ester derivative SANKIO CHEMICAL CO., LTD. (JP) 2005-08-11 US disclosed
EP-1505054-A1 PROCESS FOR PRODUCING 4-PHENYL-4-OXO-2-BUTENOIC ESTER DERIVATIVE Sankio Chemical Co., Ltd. (JP) 2005-02-09 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050176994-A1 Process for producing 4-phenyl-4-oxo-2-butenoic ester derivative HPD, PAH, CYP4A11 MEN1 3261/4885KMT2A 1717/4885NPC1 4367/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.